MPO and colitis: In comparison to treatment with hUC-MSCNC, treatment with hUC-MSCTGFB1 KD did not yield the improvements in body weight (Fig. 6A), DAI (Fig. 6B), splenic index (Fig. 6C) and colon MPO levels (Fig. 6D) in colitis mice.